ED-FPRO200

The DIASTAT™ anti-proteinase 3 (anti-PR3) test is a quantitative/qualitative enzyme-linked immunosorbent assay (ELISA) for the detection of autoantibodies specific for proteinase 3 antigen in human serum or plasma. It is intended to aid in the diagnosis of Wegener’s granulomatosis and other conditions associated with raised anti-neutrophil cytoplasmic antibodies (ANCA) and is not definitive in isolation. Autoantibody levels represent one parameter in a multicriterion diagnostic process.
 

References
Davies D.J., et al. 1982. Segmental necrotizing glomerulonephritis with antineutrophil antibody; Possible abovirus aetiology. BR Med J 285: 606.
Van der Woude F.J., et al. 1985. Autoantibodies against neutrophils and monocytes; Tool for diagnosis and marker of disease activity in Wegner’s granulomatosis. Lancet 1: 425-9.
Gross W.L., et al. 1986. ANCAs in Wegner’s granulomatosis. Lancet 5: 806.
Parleviet K.J., et al. 1988. Antibodies to components of neutrophil cytoplasm. A new diagnostic tool in patient’s with Wegner’s granulomatosis and systemic vasculitis. Q J Med 66: 55-65.
Falk R.J., et al. 1988. ANCA with specificity for myeloperoxidase in patient with systemic vasculitis and idiopathic necrotising and crescentic glomerulonephritis.N. Engl. J Med 318:1651-7.
Rump J.A., et al. 1990. A new type of perinuclear anti-neutrophil cytoplasmic antibody (panca) in active ulcerative colitis but not in Crohn’s disease. Immunobiology 181: 406-13.
Ludemann J., et al. 1990. ANCAs in Wegner’s granulomatosis recognise an elastinolytic enzyme. J Exp Med 171: 357-62.
Kao R.C., et al. 1988. Proteinase 3: A distinct human polymorphonuclear leucocyte proteinase that produces emphysema in hamsters. J Clin Invest. 82: 1963-1973.
Jennett J.C., et al. 1990. Specificity of anto-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood. 75: 2263-2264.
Lesavre P., et al. 1991. Antigen specificities and clinical distribution of ANCA in kidney diseases. Klin.Wochenschr 69: 552-557.
Cohen Tervaert J., W. et al. 1989. Association between active Wegner’s granulomatosis and anticytoplasmic antibodies. Arch Int Med 149: 2461-5.
Andrassy K., et al. 1989. Detection of clinical implication of antineutrophil cytopolasm antibodies in Wegner’s granulomatosis and rapidly progressive glomerulonephritis. Clin Nephrol 32: 159-167.
Gross W.H., et al. 1993. ANCA and associated diseases: Immunodiagnostics and pathogenic aspects. Clin Exp Immunol 91:1-12.
Kallenberg C.G., et al. 1992. Antineutrophil cytoplasmic antibodies; A still growing class of autoantibodies in inflammatory disorders. Amer J Med 93: 675-681.
Hagen E., et al. 1993. Antineutrophil cytoplasmic autoantibodies: A review of the antigens involved, the assays, and the clinical and possible pathogenenetic consequences.
Blood 81. (April 15):1996-2002.
Falk R.J., et al. 1991. ANCA detection and antigen specifity. Amer J Kidney Diseases. Vol. XVIII, No. 2 (August): 145-147.
Gross W.L., 1993. The clinical relevance of ANCA in vasculitis. 5th International ANCA Workshop, Cambridge, September.
Nölle B., et al. 1989. Anticytoplasmic autoantibodies; Their immunodiagnostic value in Wegner’s granulomatosis. Annals of Int Med III: 28-40.
Cohen Tervaert J.W., et al. 1990. Prevention of relapses in Wegner’s granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 336: 709.
Kerr G.S., et al. 1993. Limited prognostic value of changes in antiineutrophil antibody titer in patients with Wegner’s granulomatosis. Arthritis and Rheumatism 36, No. 3: 365-371.
Hauschild S., et al. 1993. Anca in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases. In Gross W.L. ed. ANCA-Associated Vasculitides. London Plenum Press. 1993 (in press).
HHS Publication No. 93-8395, 3rd ed. May 1993. Biosafety in Microb